Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

03 March 1997

Effects of the quantity of transfused blood and duration of haemodialysotherapy on potential possibility of HBV, HCV and CMV infections in chronically dialysed patients with secondary anaemia

Andrzej Steciwko, Beata Darska-Nykiel, Witold Pisarek, Robert Konarski, Beata Konarska, Andrzej Januszewski

Med Sci Monit 1997; 3(2): CR183-189 :: ID: 500689

Abstract

The aim of the present study was to determine the relationship, if any of HBV, HCV and CMV infections in patients treated with repeated haemodialyses to the amount of transfused blood. Attention was focused on a seroconversion phenomenon in HBV and HCV positive people. The study included 53 patients (22 males, aged 26-63 years, mean 44.81 years and 31 females, aged 20-70 years, mean 46.06 years) treated with repeated haemodialyses because of end-stage renal failure. In our research we estimated the number of erythrocytes given to patients during haemodialysis sessions in their haemodialysis departments. From the study group 30 patients were qualified to enter the programme of the r-hEPO treatment (after satisfying the entry criteria i.e. exclusion of inflammatory processes, supplementation of iron and folic acid to reach the normal level, control of aluminium level). The patients started their r-hEPO treatment at different times from the beginning of haemodialysotherapy. In these 30 patients in whom the r-hEPO treatment was introduced at a later stage 75,600 ml of RBCs were transfused prior to the initiation of r-hEPO therapy. In 15 additional patients anaemia caused by renal failure and loss of blood during haemodialyses was successfully treated with the RBC transfusion. These 15 patients received 42,000 ml of RBCs (the mean amount was 2,800 ml per person). In 8 patients no transfusion was performed and 5 of those were treated with erythropoietin.
Results/Conclusions: 1.The risk of HBV and HCV infection increased with the amount of RBCs transfused in groups I and II. 2. In group III the number of HBV, HCV and CMV infections and coexisting infections did not differ from the number of infections in subgroup A of group I and subgroup E of group II. 3.The possibility of an HCV infection increased with the duration of the haemodialysotherapy in all groups. 4. The risk of coexisting infections increased with the duration of the haemodialysotherapy.

Keywords: Blood Transfusion, haemodialysotherap, HBV, HCV and CMV infections, secondary anaemia

Add Comment 0 Comments

Editorial

01 February 2024 : Editorial  

Editorial: Global Health Concerns as Vaccine-Preventable Infections Including SARS-CoV-2 (JN.1), Influenza, Respiratory Syncytial Virus (RSV), and Measles Continue to Rise

Dinah V. Parums

DOI: 10.12659/MSM.943911

Med Sci Monit 2024; 30:e943911

0:00

In Press

08 Feb 2024 : Clinical Research  

Predictors of Mortality in Veterans with Amyotrophic Lateral Sclerosis: Respiratory Status and Speech Disor...

Med Sci Monit In Press; DOI: 10.12659/MSM.943288  

0:00

25 Feb 2024 : Clinical Research  

Patterns and Outcomes of Traumatic Suicides: A Retrospective Study of 132 Patients Admitted to a Turkish Me...

Med Sci Monit In Press; DOI: 10.12659/MSM.943505  

0:00

01 Feb 2024 : Review article  

Review of the Evaluation of Pulmonary Hypoplasia as an Important Determinant of Clinical Outcomes in Infant...

Med Sci Monit In Press; DOI: 10.12659/MSM.943259  

0:00

19 Feb 2024 : Clinical Research  

Diagnostic Accuracy of Ileocolic Artery and Vein Diameter for Acute Appendicitis

Med Sci Monit In Press; DOI: 10.12659/MSM.943846  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750